Transforming medical imaging for early disease detection

We are pioneering the power of molecular imaging with MRI.

We are developing new ways — based on our proprietary nanoparticle technology — to allow doctors to identify the presence of cancer sooner and more specifically than current methods.

We aspire to provide the tools to detect cancer at an earlier stage when treatment is most effective.

MagSense® Imaging Agent Technology

Simple, bio-safe molecular imaging

MagSense® technology is the first imaging agent technology to use molecularly targeted magnetic nanoparticles to tag and detect cancers. The tiny bio-safe particles act as a magnetic beacon in detecting cancer when they attach to cancer cells.

How does MagSense® imaging technology work?

Tiny magnetic nanoparticles are combined with tumor targeting molecules to produce a detectable magnetic signature.

How is MagSense® better than other imaging methods?

MagSense® technology does not use ionizing radiation or radioactive tracers and is specific for different types of cancer or other diseases.
Screen Shot 2023-10-09 at 10.17.42 AM

How will MagSense® change cancer detection?

The non-invasive imaging technology has the potential to reduce the need for biopsies and could find cancers before they progress to a later stage.

MagSense® Phase 1 Study – HER2 Breast Cancer

MagSense® HER2 Clinical Trial

Our novel MagSense® HER2 imaging agent using bio-safe magnetic nanoparticles is being tested to show whether it has the potential to non-invasively detect the spread of breast cancer to the regional lymph nodes, avoiding the need for intrusive biopsies.

We have completed enrolling patients in a multi-site Phase I study of the MagSense® HER2 imaging agent.

Imagion Biosystems

PrecisionMRX® Nanoparticles

Nanoparticles that can save lives

In addition to their use in our MagSense® technology for cancer detection using MRI (magnetic resonance imaging), our proprietary PrecisionMRX® nanoparticles can be used in a number of other applications, including MPI (magnetic particle imaging), magnetically induced hyperthermia and others.

Read about the other ways PrecisionMRX® nanoparticles are being used.

Get involved with our proprietary nanoparticles

magfi glass icon_460x460

Diagnostic Imaging

MagSense® imaging agents can be developed for many types of solid tumors and can be used at multiple stages of diagnosis including primary diagnosis, staging, and prognosis of diseases.

Other Biomedical Applications

We supply nanoparticles that can be used in third-party branded products across hyperthermia, human and animal vaccines, and cancer screening and treatments.

About Imagion Biosystems

Purchase SPIONS

We exclusively sell our superparamagnetic iron oxide PrecisionMRX® nanoparticles through Biosensis, providing them to institutions for research purposes. Multiple coatings types are available.

World class scientific collaborations & partnerships

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.